{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:05:39Z","timestamp":1779347139983,"version":"3.51.4"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>New pulmonary lesions arising during chemoimmunotherapy for non-small cell lung cancer (NSCLC) pose a common diagnostic dilemma because they may reflect tumor progression, infection, treatment-related inflammation, or other benign processes. Computed tomography remains central to surveillance, but morphology alone is sometimes insufficient for confident characterization. Contrast-enhanced ultrasonography (CEUS) can provide real-time perfusion information in peripheral pulmonary lesions and may offer incremental value in selected subpleural lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 78-year-old man with stage IIIB squamous NSCLC received four cycles of paclitaxel plus cisplatin combined with pembrolizumab. During treatment, he developed a newly detected contralateral lesion in the posterior basal segment of the left lower lobe. Transthoracic lung ultrasonography demonstrated a subpleural hypoechoic lesion measuring approximately 2.4 \u00d7 2.2\u00a0cm. CEUS showed rapid hyperenhancement in the pulmonary arterial phase, relatively homogeneous internal enhancement, and slight persistent hyperenhancement in the venous phase, favoring an inflammatory rather than a malignant lesion. This interpretation was supported by contemporaneous microbiologic evidence of respiratory infection and was subsequently confirmed clinically by marked lesion regression on short-interval follow-up computed tomography after anti-infective treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the potential adjunctive role of CEUS in the evaluation of newly detected peripheral pulmonary lesions during chemoimmunotherapy. Current evidence indicates that CEUS is most useful when integrated with clinical, laboratory, microbiologic, and cross-sectional imaging data, rather than used as a stand-alone discriminator between benign and malignant disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1838122","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:07:17Z","timestamp":1779343637000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Contrast-enhanced ultrasonography for evaluating a newly detected contralateral pulmonary lesion during non-small cell lung cancer chemoimmunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[{"name":"Day Surgery Center, General Practice Medical Center, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lusi","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongxing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.103954","article-title":"Infections in lung cancer patients undergoing immunotherapy and targeted therapy: an overview of the current scenario","volume":"184","author":"Bertaglia","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203427","article-title":"Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society","volume":"298","author":"Johkoh","year":"2021","journal-title":"Chest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230171","article-title":"Conventional and contrast-enhanced US of the lung: from performance to diagnosis","volume":"44","author":"Jim\u00e9nez-Serrano","year":"2024","journal-title":"Radiographics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2021.11.014","article-title":"WFUMB technological review: how to perform contrast-enhanced ultrasound of the lung","volume":"48","author":"Safai Zadeh","year":"2022","journal-title":"Ultrasound Med Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082302","article-title":"The role of contrast-enhanced ultrasound in the differential diagnosis of Malignant and benign subpleural lung lesions","volume":"13","author":"Boccatonda","year":"2024","journal-title":"J Clin Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2021.10.015","article-title":"Role of contrast-enhanced ultrasound in pulmonary lesions: 5-year experience at a single center","volume":"48","author":"Li","year":"2022","journal-title":"Ultrasound Med Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010081","article-title":"Impact of infections in patients receiving pembrolizumab-based therapies for non-small cell lung cancer","volume":"15","author":"Burns","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.02.032","article-title":"Immune checkpoint inhibitor-related pneumonitis in lung cancer: real-world incidence, risk factors, and management practices across six health care centers in North Carolina","volume":"160","author":"Atchley","year":"2021","journal-title":"Chest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14176133","article-title":"Lung toxicity from immune checkpoint inhibitors: a diagnostic approach","volume":"14","author":"Casal","year":"2025","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17101697","article-title":"Role of quantitative CEUS in the diagnosis of peripheral pulmonary lesions: a systematic review","volume":"17","author":"Boccatonda","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2006.06.018","article-title":"Contrast-enhanced ultrasound (CEUS) for the study of peripheral lung lesions: a preliminary study","volume":"32","author":"Sperandeo","year":"2006","journal-title":"Ultrasound Med Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jus.2008.05.008","article-title":"Contrast enhanced ultrasonography (CEUS) in peripheral lung lesions: a study of 60 cases","volume":"11","author":"Caremani","year":"2008","journal-title":"J Ultrasound"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2011.08.003","article-title":"The feasibility of low-mechanical-index contrast-enhanced ultrasound (CEUS) in distinguishing Malignant from benign thoracic lesions","volume":"37","author":"Qureshi","year":"2011","journal-title":"Ultrasound Med Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.578884","article-title":"Time difference of arrival on contrast-enhanced ultrasound in distinguishing benign inflammation from Malignant peripheral pulmonary lesions","volume":"10","author":"Tang","year":"2020","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021204642","article-title":"US contrast agent arrival time difference ratio for benign versus Malignant subpleural pulmonary lesions","volume":"301","author":"Bi","year":"2021","journal-title":"Radiology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jum.15804","article-title":"Application of contrast-enhanced ultrasound in the differential diagnosis of benign and Malignant subpleural pulmonary lesions","volume":"41","author":"Shen","year":"2022","journal-title":"J Ultrasound Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000029605","article-title":"Application value of contrast-enhanced ultrasound in the diagnosis of peripheral pulmonary focal lesions","volume":"101","author":"Bai","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-208913","article-title":"Contrast-enhanced ultrasound does not discriminate between community-acquired pneumonia and lung cancer","volume":"72","author":"Sperandeo","year":"2017","journal-title":"Thorax"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1838122\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:07:28Z","timestamp":1779343648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1838122\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2026.1838122"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1838122","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"article-number":"1838122"}}